Role of metformin in the diagnosis, prevention, and treatment of hepatocellular carcinoma / 中南大学学报(医学版)
Journal of Central South University(Medical Sciences)
; (12): 364-373, 2022.
Article
in En
| WPRIM
| ID: wpr-928979
Responsible library:
WPRO
ABSTRACT
Hepatocellular carcinoma is one of the most common malignant tumors in the world. Although there are many options for the treatment of hepatocellular carcinoma, such as surgical resection, interventional therapy, radiotherapy, chemotherapy, targeted therapy and liver transplantation, the poor therapeutic effect seriously reduces the quality of life for patients and also increases the social and economic burden. Metformin is originally used as the first-line drug for type 2 diabetes, but it has been found to play a certain effect in the prevention and treatment of malignant tumor. The potential roles of metformin against hepatocellular carcinoma, such as regulation of the microenvironment, proliferation signal pathway, metabolism, invasion and metastasis, apoptosis, autophagy, and epigenetics of hepatoma cells. It provides a new choice for the prevention and treatment of hepatocellular carcinoma.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Quality of Life
/
Carcinoma, Hepatocellular
/
Cell Line, Tumor
/
Cell Proliferation
/
Diabetes Mellitus, Type 2
/
Tumor Microenvironment
/
Liver Neoplasms
/
Metformin
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
Journal of Central South University(Medical Sciences)
Year:
2022
Type:
Article